PMID: 9539786May 16, 1998Paper

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

Proceedings of the National Academy of Sciences of the United States of America
S C GhivizzaniP D Robbins

Abstract

Adenoviral vectors were used to deliver genes encoding a soluble interleukin 1 (IL-1)-type I receptor-IgG fusion protein and/or a soluble type I tumor necrosis factor alpha (TNFalpha) receptor-IgG fusion protein directly to the knees of rabbits with antigen-induced arthritis. When tested individually, knees receiving the soluble IL-1 receptor had significantly reduced cartilage matrix degradation and white blood cell infiltration into the joint space. Delivery of the soluble TNFalpha receptor was less effective, having only a moderate effect on white blood cell infiltration and no effect on cartilage breakdown. When both soluble receptors were used together, there was a greater inhibition of white blood cell infiltration and cartilage breakdown with a considerable reduction of synovitis. Interestingly, anti-arthritic effects were also seen in contralateral control knees receiving only a marker gene, suggesting that sustained local inhibition of disease activity in one joint may confer an anti-arthritic effect on other joints. These results suggest that local intra-articular gene transfer could be used to treat systemic polyarticular arthritides.

References

Aug 1, 1992·Annals of the Rheumatic Diseases·N E GarrettD R Blake
Oct 1, 1988·In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association·H I GeorgescuC H Evans
Feb 1, 1987·Molecular and Cellular Biology·J R de WetS Subramani
Apr 1, 1973·Virology·F L Graham, A J van der Eb
Nov 1, 1994·General Pharmacology·D T ScottW R Ferrell
May 10, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y YangJ M Wilson
Jan 4, 1994·Proceedings of the National Academy of Sciences of the United States of America·J KollsB Beutler
Aug 1, 1993·The Journal of Clinical Investigation·B J RoesslerB L Davidson
Jan 1, 1993·Advances in Immunology·W P Arend
Jan 9, 1996·Proceedings of the National Academy of Sciences of the United States of America·S S MakarovJ H Schwab
Nov 1, 1996·Journal of Virology·N MitterederB C Trapnell
Mar 1, 1997·Arthritis and Rheumatism·L W MorelandW J Koopman
Jan 1, 1997·Advances in Immunology·M FeldmannR N Maini
May 1, 1997·Biochemical Society Transactions·R KangC H Evans
Jul 1, 1997·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P Yeh, M Perricaudet

❮ Previous
Next ❯

Citations

Jan 27, 1999·Arthritis and Rheumatism·C H EvansP D Robbins
Mar 29, 2002·Arthritis and Rheumatism·Jong-Mook KimSunyoung Kim
Nov 20, 2002·The Journal of Gene Medicine·Natacha BessisMarie-Christophe Boissier
Dec 4, 1998·Springer Seminars in Immunopathology·P D RobbinsY Chernajovsky
Jan 8, 2008·Modern Rheumatology·Russell S Traister, Raphael Hirsch
Apr 6, 2004·Developmental and Comparative Immunology·Sumathi SubramaniamCharles Cunningham
Apr 20, 2001·Archives of Oral Biology·K TominagaS Kopp
Nov 8, 2001·European Journal of Pharmacology·M Pohl, J Braz
Aug 12, 1999·European Journal of Pharmacology·J Pfeilschifter, H Mühl
Oct 21, 2003·The Journal of Thoracic and Cardiovascular Surgery·Tsutomu TagawaG Alexander Patterson
Dec 31, 2003·Biomaterials·Peter M van der KraanWim B van den Berg
Nov 10, 2000·Advanced Drug Delivery Reviews·M L Hedley
Oct 11, 2003·Biotechnology Advances·A MhashilkarR Ramesh
Oct 26, 2001·Current Opinion in Immunology·I H Tarner, C G Fathman
Jul 11, 2003·Progress in Retinal and Eye Research·Uwe Pleyer, Thomas Ritter
Nov 14, 2000·Molecular Medicine Today·S S Makarov
Apr 20, 2001·Cytokine & Growth Factor Reviews·B SpörriD Lottaz
Sep 11, 2002·Cytokine & Growth Factor Reviews·William P Arend
Feb 22, 2001·Drug Discovery Today·S C. GhivizzaniC H. Evans
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Falk MoritzSteffen Gay
Aug 26, 2006·Nature Clinical Practice. Rheumatology·Christopher H EvansPaul D Robbins
Apr 19, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Elvire GouzeSteven C Ghivizzani
Nov 7, 2008·Human Gene Therapy·Peter WehlingChristopher H Evans

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.